Glp

•

6 j'aime•2,658 vues

National Institute of Biologics

Technologie Business

GLP: GOOD LABORATORY PRACTICE ,[object Object],[object Object],[object Object]

HISTORY ,[object Object],[object Object],[object Object],[object Object],[object Object]

WHY WAS GLP CREATED? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FAMOUS EXAMPLE ,[object Object],[object Object],[object Object],[object Object],[object Object]

OBJECTIVES OF GLP ,[object Object],[object Object],[object Object]

MISSION OF GLP ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Standard Operating Procedures (SOP) ,[object Object],[object Object],[object Object],[object Object]

SOP ,[object Object],[object Object],[object Object],[object Object],[object Object]

Statistical Procedures for Data Evaluation ,[object Object],[object Object],[object Object]

Instrumentation Validation ,[object Object],[object Object],[object Object],[object Object]

Instrument Validation (cont) ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Reagent/ Materials Certification ,[object Object],[object Object]

Reagents and Solutions cont ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Analyst Certification ,[object Object],[object Object],[object Object],[object Object]

Laboratory Certification ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Specimen/Sample Tracking ,[object Object],[object Object],[object Object]

Documentation and Maintenance of Records ,[object Object],[object Object],[object Object]

Important questions to be answered for any analytical instrument ,[object Object],[object Object],[object Object],[object Object],[object Object]

What happens if a workplace does not comply with federal Good Laboratory Practice standards?

Disqualification of a Facility ,[object Object],[object Object]

Possible Violations ,[object Object],[object Object],[object Object]

Grounds for Disqualification ,[object Object],[object Object],[object Object]

Consequences of Noncompliance ,[object Object],[object Object],[object Object],[object Object],[object Object]

Upon Disqualification… ,[object Object],[object Object],[object Object],[object Object]

Upon Disqualification… ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Upon Disqualification… ,[object Object],[object Object],[object Object]

Reinstatement of a Disqualified Facility ,[object Object],[object Object]

References ,[object Object],[object Object]

Contenu connexe

Tendances

Clinical trial monitoringDr. Ashish singh parihar

GOOD LABORATORY PRACTICESSurabhi Bhaurya

Regulatory agenciesUrmila Aswar

PPT ON GOOD LABORATORY PRACTICES (GLP)GOVIND YADAV

Central drug standard control organisationbdvfgbdhg

Schedule ypharmacologyseminars

CIOMS (1).pptxSanjay522244

Essential documentsRajeev Sahai

Investigational new drug (IND)Manish Rajput

New drug approvalSuvarta Maru

Good laboratory practices (GLP)DIVYA BHARDWAJ

Regulatory affairsDipak Bhingardeve

CroShahbaz Khan

Case Report Form (CRF)Neelam Shinde

good laboratory practicesrasika walunj

Detection, reporting and management of adverse eventsKatla Swapna

Standard operating procedure in pharmaceutical industries,SOP,MFR,Master Form...SimranKukreja4

Documentation clinical trialankit sharma

New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)Vamsikrishna Reddy

Introduction to clinical research - IIPradeep H

Tendances (20)

Clinical trial monitoring

GOOD LABORATORY PRACTICES

Regulatory agencies

PPT ON GOOD LABORATORY PRACTICES (GLP)

Central drug standard control organisation

Schedule y

CIOMS (1).pptx

Essential documents

Investigational new drug (IND)

New drug approval

Good laboratory practices (GLP)

Regulatory affairs

Cro

Case Report Form (CRF)

good laboratory practices

Detection, reporting and management of adverse events

Standard operating procedure in pharmaceutical industries,SOP,MFR,Master Form...

Documentation clinical trial

New Drug Application(Nda) Vs Abbreviated New Drug Application (Anda)

Introduction to clinical research - II

Similaire à Glp

GLP.pptAnilSingh899780

GLP.pptPiyushArora139764

Glpceutics1315

GlpMalla Reddy College of Pharmacy

Good Laboratory Practice (GLP)Shoab Malek (Certified Quality Auditor)

GLPrasikawalunj

good laboratory practices rasika walunj

Good Laboratory Practicespp_shivgunde

Good laboratory practicesNasir Nazeer

Good Laboratory Practices.pptxVUJJINIKHILKUMAR

Good laboratory practices (GLP) himanshuhimanshu kamboj

GLP_1.pdfPrashant Pisalkar

Glp.tusharharde1234

GLP Good Laboratory Practices PresentatiAngelFlores740939

good-ward.pptWalahassan4

Cro perspectivesPRAFULLA PAWAR

GLP DRA.pptxDiwakar Sudhakar Shukla

GOOD LABORATORY PRACTICE by ILyas Mphil student.pptxAtaUrRahman50751

Audit monitoring and inspections cro perspectivesDr Prashant Bodhe

Training ProgramObaid Ali / Roohi B. Obaid

Similaire à Glp (20)

GLP.ppt

Glp

Good Laboratory Practice (GLP)

GLP

good laboratory practices

Good Laboratory Practices

Good laboratory practices

Good Laboratory Practices.pptx

Good laboratory practices (GLP) himanshu

GLP_1.pdf

Glp.

GLP Good Laboratory Practices Presentati

good-ward.ppt

Cro perspectives

GLP DRA.pptx

GOOD LABORATORY PRACTICE by ILyas Mphil student.pptx

Audit monitoring and inspections cro perspectives

Training Program

Plus de National Institute of Biologics

Waters protein therapeutics application proctocolsNational Institute of Biologics

Potential aggregation prone regions in biotherapeuticsNational Institute of Biologics

How the biologics landscape is evolvingNational Institute of Biologics

Evaluation of antibody drugs quality safetyNational Institute of Biologics

Approved m abs_feb_2015National Institute of Biologics

Translating next generation sequencing to practiceNational Institute of Biologics

From biomarkers to diagnostics –the road to successNational Institute of Biologics

Defining your-target-product-profile in-vitro-diagnostic-productsNational Institute of Biologics

Accelerating development and approval of targeted cancer therapiesNational Institute of Biologics

Canonical structures for the hypervariable regions of immunoglobulinsNational Institute of Biologics

Canonical correlationNational Institute of Biologics

Development trends for human monoclonal antibody therapeuticsNational Institute of Biologics

Therapeutic fc fusion proteins and peptides as successful alternatives to ant...National Institute of Biologics

Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...National Institute of Biologics

Therapeutic antibodies for autoimmunity and inflammationNational Institute of Biologics

Introduction to current and future protein therapeutics - a protein engineeri...National Institute of Biologics

Pharmaceutical monoclonal antibodies production - guidelines to cell engine...National Institute of Biologics

Intended use of reference products & who international standards or reference...National Institute of Biologics

How dissimilarly similar are biosimilarsNational Institute of Biologics

Evaluation of similar biotherapeutic products (SBP's) scientiﬁc principles ...National Institute of Biologics

Plus de National Institute of Biologics (20)

Waters protein therapeutics application proctocols

Potential aggregation prone regions in biotherapeutics

How the biologics landscape is evolving

Evaluation of antibody drugs quality safety

Approved m abs_feb_2015

Translating next generation sequencing to practice

From biomarkers to diagnostics –the road to success

Defining your-target-product-profile in-vitro-diagnostic-products

Accelerating development and approval of targeted cancer therapies

Canonical structures for the hypervariable regions of immunoglobulins

Canonical correlation

Development trends for human monoclonal antibody therapeutics

Therapeutic fc fusion proteins and peptides as successful alternatives to ant...

Fc fusion proteins and fc rn - structural insights for longer-lasting and mor...

Therapeutic antibodies for autoimmunity and inflammation

Introduction to current and future protein therapeutics - a protein engineeri...

Pharmaceutical monoclonal antibodies production - guidelines to cell engine...

Intended use of reference products & who international standards or reference...

How dissimilarly similar are biosimilars

Evaluation of similar biotherapeutic products (SBP's) scientiﬁc principles ...

Dernier

TeamStation AI System Report LATAM IT Salaries 2024Lonnie McRorey

New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada

Human Factors of XR: Using Human Factors to Design XR SystemsMark Billinghurst

DevoxxFR 2024 Reproducible Builds with Apache MavenHervé Boutemy

DSPy a system for AI to Write Prompts and Do Fine TuningLars Bell

What's New in Teams Calling, Meetings and Devices March 2024Stephanie Beckett

Designing IA for AI - Information Architecture Conference 2024Enterprise Knowledge

"ML in Production",Oleksandr BaganFwdays

Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfPrecisely

Take control of your SAP testing with UiPath Test SuiteDianaGray10

E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptxnull - The Open Security Community

CloudStudio User manual (basic edition):comworks

Developer Data Modeling Mistakes: From Postgres to NoSQLScyllaDB

How to write a Business Continuity PlanDatabarracks

Ensuring Technical Readiness For Copilot in Microsoft 3652toLead Limited

SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero

DMCC Future of Trade Web3 - Special EditionDubai Multi Commodity Centre

Artificial intelligence in cctv survelliance.pptxhariprasad279825

"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays

Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024BookNet Canada

Dernier (20)

TeamStation AI System Report LATAM IT Salaries 2024

New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024

Human Factors of XR: Using Human Factors to Design XR Systems

DevoxxFR 2024 Reproducible Builds with Apache Maven

DSPy a system for AI to Write Prompts and Do Fine Tuning

What's New in Teams Calling, Meetings and Devices March 2024

Designing IA for AI - Information Architecture Conference 2024

"ML in Production",Oleksandr Bagan

Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf

Take control of your SAP testing with UiPath Test Suite

E-Vehicle_Hacking_by_Parul Sharma_null_owasp.pptx

CloudStudio User manual (basic edition):

Developer Data Modeling Mistakes: From Postgres to NoSQL

How to write a Business Continuity Plan

Ensuring Technical Readiness For Copilot in Microsoft 365

SIP trunking in Janus @ Kamailio World 2024

DMCC Future of Trade Web3 - Special Edition

Artificial intelligence in cctv survelliance.pptx

"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack

Transcript: New from BookNet Canada for 2024: BNC CataList - Tech Forum 2024

Glp

1. GLP

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20. What happens if a workplace does not comply with federal Good Laboratory Practice standards?

21.

22.

23.

24.

25.

26.

27.

28.

29.

30.

Glp

Recommandé